NO20071806L - Tablets with site and time controlled gastrointestinal release of active ingredient. - Google Patents

Tablets with site and time controlled gastrointestinal release of active ingredient.

Info

Publication number
NO20071806L
NO20071806L NO20071806A NO20071806A NO20071806L NO 20071806 L NO20071806 L NO 20071806L NO 20071806 A NO20071806 A NO 20071806A NO 20071806 A NO20071806 A NO 20071806A NO 20071806 L NO20071806 L NO 20071806L
Authority
NO
Norway
Prior art keywords
site
active ingredient
tablets
time controlled
controlled gastrointestinal
Prior art date
Application number
NO20071806A
Other languages
Norwegian (no)
Inventor
Achim Schaffler
Original Assignee
Nitec Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102004043863A external-priority patent/DE102004043863A1/en
Application filed by Nitec Pharma Ag filed Critical Nitec Pharma Ag
Publication of NO20071806L publication Critical patent/NO20071806L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse beskriver en farmasøytisk doseringsform med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.The present invention describes a pharmaceutical dosage form with site and time controlled gastrointestinal release of active ingredient.

NO20071806A 2004-09-10 2007-04-03 Tablets with site and time controlled gastrointestinal release of active ingredient. NO20071806L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004043863A DE102004043863A1 (en) 2004-09-10 2004-09-10 Tablets with local and time-controlled drug release in the gastrointestinal tract
US11/216,469 US20060057200A1 (en) 2004-09-10 2005-09-01 Tablets with site- and time-controlled gastrointestinal release of active ingredient
PCT/EP2005/009726 WO2006027266A1 (en) 2004-09-10 2005-09-09 Tablets with site time-controlled gastrointestinal release of active ingredient

Publications (1)

Publication Number Publication Date
NO20071806L true NO20071806L (en) 2007-06-08

Family

ID=36036090

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071806A NO20071806L (en) 2004-09-10 2007-04-03 Tablets with site and time controlled gastrointestinal release of active ingredient.

Country Status (7)

Country Link
EP (1) EP1807058A1 (en)
JP (1) JP5134955B2 (en)
KR (1) KR101363563B1 (en)
AU (1) AU2005281797B2 (en)
CA (1) CA2579732C (en)
NO (1) NO20071806L (en)
WO (1) WO2006027266A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004043863A1 (en) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tablets with local and time-controlled drug release in the gastrointestinal tract
PT2049123E (en) * 2006-08-03 2013-03-06 Horizon Pharma Ag Delayed-release glucocorticoid treatment of rheumatoid disease
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
EP2391369A1 (en) 2009-01-26 2011-12-07 Nitec Pharma AG Delayed-release glucocorticoid treatment of asthma
WO2014052237A1 (en) 2012-09-26 2014-04-03 Aragon Pharmaceuticals, Inc. Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer
EP2945628B1 (en) * 2013-01-15 2020-04-15 Aragon Pharmaceuticals, Inc. Androgen receptor modulator in combination with abiraterone acetate and prednisone for treating prostate cancer
WO2018023017A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Methods of treating prostate cancer
KR20240096623A (en) 2017-10-16 2024-06-26 아라곤 파마슈티컬스, 인코포레이티드 Anti-androgens for the treatment of non-metastatic castration-resistant
JP2021120357A (en) * 2020-01-30 2021-08-19 サンノーバ株式会社 tablet

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2521848B2 (en) * 1990-07-02 1996-08-07 ベーリンガー マンハイム ゲーエムベーハー Method for preparing shaped and compressed sustained release unit dosage form and compressed unit dosage form thus obtained
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
IT1282576B1 (en) * 1996-02-06 1998-03-31 Jagotec Ag PHARMACEUTICAL TABLET SUITABLE TO GIVE THE ACTIVE SUBSTANCE IN SUBSEQUENT AND PREDETERMINABLE TIMES
JP2001010950A (en) * 1999-06-29 2001-01-16 Taiyo Yakuhin Kogyo Kk Medicinal composition having stable and good drug releasability
DE10012555A1 (en) * 2000-03-15 2001-09-20 Merck Patent Gmbh Composition for rapid release of corticoid drugs after delay period, useful for drug delivery during the night, e.g. for preventing asthma, or for delivery to colon for treating inflammatory bowel disease
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
KR20040047747A (en) * 2001-03-13 2004-06-05 펜웨스트 파머슈티칼즈 컴파니 Chronotherapeutic dosage forms
KR20040091135A (en) * 2002-03-14 2004-10-27 다이이찌 산토리 파마 가부시키가이샤 Tablet containing pilsicainide hydrochloride(dry)
ES2335008T3 (en) * 2003-04-24 2010-03-18 Jagotec Ag COMPRESSED WITH COLORED NUCLEUS.
DE102004043863A1 (en) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tablets with local and time-controlled drug release in the gastrointestinal tract

Also Published As

Publication number Publication date
CA2579732C (en) 2014-08-12
KR101363563B1 (en) 2014-02-14
AU2005281797A1 (en) 2006-03-16
AU2005281797B2 (en) 2011-07-07
EP1807058A1 (en) 2007-07-18
JP2008512419A (en) 2008-04-24
WO2006027266A1 (en) 2006-03-16
KR20070098989A (en) 2007-10-08
JP5134955B2 (en) 2013-01-30
CA2579732A1 (en) 2006-03-16

Similar Documents

Publication Publication Date Title
EP1824442A4 (en) PHARMACEUTICAL AND THERAPEUTIC COMPOSITIONS DERIVED FROM GARCINIA MANGOSTANA L.
MX2007002898A (en) Tablets with site time-controlled gastrointestinal release of active ingredient.
ITMI20011337A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS WITH MODIFIED RELEASE OF THE ACTIVE INGREDIENT
MX374396B (en) SUBLINGUAL FENTANYL SPRAY.
IS8060A (en) Dermatogenic dosage form for intravenous administration containing the active ingredient and the opposite component at the remote side of the active ingredient
NO20064041L (en) Substituted pyrazoline compositions, their preparation and use as drugs
PL2878297T3 (en) DRUGS FOR THE TREATMENT OR PREVENTION OF FIBERIAL DISEASES
NO20053224D0 (en) Patient controlled drug administration device.
EP2045251A4 (en) UBC13-EUV INHIBITOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC APPLICATIONS
JP2007504142A5 (en) Solid drug dosage form comprising HIV protease inhibitor solid dispersion
UA103347C2 (en) Pharmaceutical dosage form comprising nifedipine or nisoldipine and angiotensin-ii antagonist and/or diuretic
PH12013502277A1 (en) Modified release of 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-5-(4 methyl-1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide solubilized using organic acids
DK1957110T3 (en) PROCEDURE FOR THE PREPARATION OF CHEWABLE DOSAGE FORMS FOR MEDICINE ADMINISTRATION AND PRODUCTS THEREOF
MX366832B (en) Conveniently implantable sustained release drug compositions.
IL188583A0 (en) Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist
CY1113462T1 (en) DOSAGE FORM CONTENTS Pantoprazole as an Active Ingredient
EA201201202A1 (en) ORAL PHARMACEUTICAL COMPOSITION CONTAINING DABIGATRANE EXTILE
IL176519A0 (en) Directly compressible pharmaceutical composition for the oral administration of cci-779
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
DK1641438T3 (en) Process for preparing the amorphous form of a drug
FI20000780L (en) Oral dosage form for controlled release of the drug
ITMI20011338A0 (en) ORAL PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE OF THE ACTIVE INGREDIENT
UY31662A1 (en) COMPOSITIONS OF RANITIDINE TABLETS OF ORAL DISINTEGRATION AND ITS METHODS OF ELABORATION.
FR2915684B1 (en) PARTICLES BASED ON POLYELECTROLYTES AND MODIFIED RELEASE ACTIVE INGREDIENTS AND PHARMACEUTICAL FORMULATIONS CONTAINING THESE PARTICLES

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application